Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?

The medical device manufacturer has raised its dividend payout for 47 consecutive years.Shares of Medtronic (MDT 1.12%) responded poorly to the company's latest quarterly results announcement. The market knocked the stock about 5% lower on May 23, but some analysts who follow the medical device manufacturer recognized some positive signals.Wells Fargo analyst Larry Biegelsen raised the bank's price target on Medtronic by $3 to $105 per share and maintained a positive rating. The new target implies a gain of ...